The megaround rebound: Private biotechs rack up $100M+ financings
Big money is back.
Over the past 12 weeks, biotech startups have raised $100 million-plus megarounds from venture capitalists at a pace that could approach …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
